These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34995512)

  • 21. Pharmacists as facilitators of pharmacogenomic guidance for antidepressant drug selection and dosing.
    Bishop JR
    Clin Transl Sci; 2021 Jul; 14(4):1206-1209. PubMed ID: 34058073
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacogenetic insights into depression and antidepressant response: does sex matter?
    Pitychoutis PM; Zisaki A; Dalla C; Papadopoulou-Daifoti Z
    Curr Pharm Des; 2010; 16(20):2214-23. PubMed ID: 20459391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spatiotemporal molecular medicine: A new era of clinical and translational medicine.
    Wang X; Fan J
    Clin Transl Med; 2021 Jan; 11(1):e294. PubMed ID: 33463066
    [No Abstract]   [Full Text] [Related]  

  • 24. Depression: a change of mind.
    Anthes E
    Nature; 2014 Nov; 515(7526):185-7. PubMed ID: 25391944
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of depression: the current state and perspectives of the development of pharmacological studies].
    Ivanetz NN; Tikhonova YG; Kinkulkina MA; Avdeeva TI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(10):108-16. PubMed ID: 25614913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The keys to improving depression outcomes.
    Rizvi SJ; Kennedy SH
    Eur Neuropsychopharmacol; 2011 Sep; 21 Suppl 4():S694-702. PubMed ID: 21924209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Translational evidence for ayahuasca as an antidepressant: what's next?
    Dos Santos RG; Bouso JC
    Braz J Psychiatry; 2019; 41(4):275-276. PubMed ID: 31365714
    [No Abstract]   [Full Text] [Related]  

  • 28. Current treatment concepts in depression.
    Judd FK; Norman TR
    Aust Fam Physician; 1990 Sep; 19(9):1347-54. PubMed ID: 2222310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antidepressive agents].
    Harlay A
    Infirm Fr; 1984 Oct; (258):13-7. PubMed ID: 6569023
    [No Abstract]   [Full Text] [Related]  

  • 30. Lithium treatment of depression.
    Noyes R; Dempsey GM
    Dis Nerv Syst; 1974 Dec; 35(12):573-6. PubMed ID: 17896758
    [No Abstract]   [Full Text] [Related]  

  • 31. Choline and N-acetyl aspartate levels in the dorsolateral prefrontal cortex at the beginning of the recovery phase as markers of increased risk for depressive episode recurrence under different duration of maintenance therapy and after it: a retrospective cohort study.
    Henigsberg N; Savić A; Radoš M; Šarac H; Radoš M; Ozretić D; Bajs Janović M; Erdeljić Turk V; Šečić A; Kalember P; Hrabač P
    Croat Med J; 2018 Oct; 59(5):244-252. PubMed ID: 30394016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and safety of bilateral rTMS in medication-resistant depression.
    Cohen CI; Amassian VE; Akande B; Maccabee PJ
    J Clin Psychiatry; 2003 May; 64(5):613-4. PubMed ID: 12755672
    [No Abstract]   [Full Text] [Related]  

  • 33. Are personalised treatments of adult depression finally within reach?
    Cuijpers P; Christensen H
    Epidemiol Psychiatr Sci; 2017 Feb; 26(1):40-42. PubMed ID: 26965477
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of antidepressants: similar but different.
    Matthews PR
    Int J Neuropsychopharmacol; 2011 Nov; 14(10):1433-4; author reply 1435-7. PubMed ID: 21489347
    [No Abstract]   [Full Text] [Related]  

  • 35. Prefrontal cortical-amygdalar metabolism in major depression.
    Drevets WC
    Ann N Y Acad Sci; 1999 Jun; 877():614-37. PubMed ID: 10415674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Update on clinical investigation of novel drugs for the treatment of depression: current situation and challenge].
    Nakabayashi T
    Nihon Yakurigaku Zasshi; 2015 Oct; 146(4):185-90. PubMed ID: 26656961
    [No Abstract]   [Full Text] [Related]  

  • 37. Mitochondrial proteomics investigation of frontal cortex in an animal model of depression: Focus on chronic antidepressant drugs treatment.
    Głombik K; Stachowicz A; Trojan E; Ślusarczyk J; Suski M; Chamera K; Kotarska K; Olszanecki R; Basta-Kaim A
    Pharmacol Rep; 2018 Apr; 70(2):322-330. PubMed ID: 29477041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological aspects of depression: a review of the etiology and mechanisms of action and clinical assessment of antidepressants.
    Ankier SI; Leonard BE
    Int Rev Neurobiol; 1986; 28():183-239. PubMed ID: 2879809
    [No Abstract]   [Full Text] [Related]  

  • 39. Synaptoproteomics of learned helpless rats involve energy metabolism and cellular remodeling pathways in depressive-like behavior and antidepressant response.
    Mallei A; Giambelli R; Gass P; Racagni G; Mathé AA; Vollmayr B; Popoli M
    Neuropharmacology; 2011 Jun; 60(7-8):1243-53. PubMed ID: 21195720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microglial NLRP3 inflammasome activation mediates IL-1β-related inflammation in prefrontal cortex of depressive rats.
    Pan Y; Chen XY; Zhang QY; Kong LD
    Brain Behav Immun; 2014 Oct; 41():90-100. PubMed ID: 24859041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.